The global photoacoustic tomography market is projected to reach US$ 79.2 million in 2022. Based on the report, sales of photoacoustic tomography are likely to soar at a CAGR of 13.60% to reach an evaluation of US$ 320.9 million by 2032.
Demand for photoacoustic tomography is on the rise owing to awareness about cancer diagnosis in its early stages and the prevalence of cancer.
Photoacoustic tomography is a non-invasive biomedical hybrid imaging technique that merges acoustic detection and optical excitation to recognize high resolution, high contrast, and deep penetration in biological tissues. This technique acquires images of biological tissues without using excising tissue or ionizing radiation. Photoacoustic tomography functions on the photoacoustic effect that transforms absorbed optical energy into acoustic energy. This is said to drive the growth of the photoacoustic tomography market.
| Report Attribute | Details |
|---|---|
| Photoacoustic Tomography Market Value (2022) | US$ 79.2 Million |
| Photoacoustic Tomography Market Anticipated Value (2032) | US$ 320.9 Million |
| Photoacoustic Tomography Projected Growth Rate (2022 to 2032) | 13.60% |
The growth of the global photoacoustic tomography market is said to surge during the forecast period owing to the fact that this technique can be utilized in detecting physiological properties such as hemoglobin concentration and oxygen saturation. Furthermore, the functioning of the brain, tumor mapping, methemoglobin measuring, skin melanoma detection, and various others can be monitored with the assistance of the photoacoustic tomography technique. Also, with the help of photoacoustic tomography, 2D and 3D images can be formed.
The rising prevalence of breast cancer across the world, combined with a greater number of research studies in the fields of non-ionizing radiation for imaging, is propelling the growth of the photoacoustic tomography market.
For example, WHO stated that in 2020 there were nearly 2.3 million women diagnosed with breast cancer and approximately 685,000 deaths across the world. Furthermore, the rising extent of applications is equally impacting the expansion of the global market. Photoacoustic tomography is much enhanced as compared to any other diagnostic imaging system.
Photoacoustic tomography has faster imaging speed and sensitivity along with diagnostic accuracy and better handling. One of the key advantages of this technique is that it can be applied clinically on ultrasound machines, enabling molecular and cellular imaging to be added to the spectrum of traditional ultrasound imaging.
Several studies have shown the use of photoacoustic tomography imaging techniques for numerous applications. Also, multiple research activities have been conducted over the last ten years, and positive results on various diseases are studied with this technique, such as wound healing, cancer, brain disorders, etc.
Photoacoustic tomography delivers both functional as well as structural, optical information for deep tissues with scalable ultrasound resolution. Additional application of this technique in pre-clinical studies, as well as potential application in disease diagnosis and monitoring, is resulting in the lucrative growth of the global photoacoustic tomography market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Recent developments by medical equipment manufacturers and various research groups in the past few years have resulted in increased adoption of photoacoustic tomography imaging technology in the medical segment, which boosts the market's growth during the forecast period.
Growth in pre-clinical studies about photoacoustic tomography in various research and academic institutes are some of the key factors predicted to promote the growth of the photoacoustic tomography market in the future. Moreover, the expanding imaging technique of photoacoustic imaging is predicted to fuel the market growth during the forecast period.
The increasing prevalence of chronic diseases such as cardiovascular and cancer are grave concern in the healthcare industry. Still, these factors are said to support the lucrative growth of the photoacoustic tomography market. WHO says that in 2020, one of the leading causes of death was cancer across the world. This accounted for nearly 10 million deaths, with the most common type of cancer being lung and breast cancers.
Increasing awareness and the need for cancer detection at early stages have been driving key enhancements in medical and technology systems. In addition, advanced technology in non-invasive diagnosis and an increase in the application of non-ionizing radiation in healthcare science will encourage the demand for photoacoustic tomography to a substantial degree.
Several technologies, such as intravascular photoacoustic tomography, intravascular ultrasound (IVUS), and angiography, are used to detect cardiovascular diseases. The combined IVPA and IVUS imaging is utilized to characterize and detect atherosclerotic plaques. The demand for photoacoustic tomography is surging as it offers several advantages in atherosclerotic plaque imaging as compared to other techniques.
An upsurge in non-transmissible diseases cases, increasing demand for enhanced imaging methods, more cases of skin and eye-related diseases, surging demand by various oncology departments, and escalating awareness pertaining to early diagnosis procedures are some of the primary factors which promote the growth of photoacoustic tomography during the forecast period.
Additionally, support from the government is likely to further render prospective opportunities for the market growth of photoacoustic tomography in the future. However, photoacoustic imaging is expensive. This factor, coupled with strict regulations pertaining to laser usage, is anticipated to restrict the revenue growth of the market during the forecast period.
Lasers are known to be extremely precise and have high accuracy. However, they are cost-intensive systems that need high investments and funds. Therefore, new players find it challenging to penetrate and sustain in the market. Moreover, in the flow of research and development, surveillance in the case of pre-clinical applications on animals for research acts as a barrier. Lastly, the lack of skilled labor for the smooth operation of photoacoustic tomography is also said to hamper the growth of this market during the forecast period.
North America is dominating the global photoacoustic tomography market owing to rising pre-clinical studies related to this technique in several research and academic institutions. North America is responsible for holding a market share of 29.20% of the global market. The growing geriatric population and increasing cancer cases are among the key driving factors in the North American photoacoustic tomography market.
Safe non-ionizing radiation used in photoacoustic technology and the growing healthcare industry are key factors that are driving the market in this region. The initial cost of photoacoustic tomography is very high. This, along with the developing technology, can pose a challenge for the North American photoacoustic tomography market.
There is a constant upgradation in technology and features, which results in vendors attracting new consumers and growing their footprints in the upcoming markets. This factor is said to promote the growth of the photoacoustic tomography market in North America.
Principal Consultant
The increasing aged population coupled with the growing prevalence of cancer is the major driving factor of the Europe photoacoustic tomography market. Europe is responsible for holding a market share of 37.40% of the global market. Government support in developing innovative equipment, the trend of adoption of technology, and investment in research activities are accountable for the growth of the market in this region.
Increasing cases of fungal disease and infection are anticipated to promote market growth during the forecast period. In Europe, a country like Germany is anticipated to lead the market owing to constant research and the primary manufacturer being a major player in the industry.
The photoacoustic tomography industry opens numerous opportunities for new participants who concentrate on segments such as 3D imaging. For instance, in 2021, Luxonus, a Japanese start-up, produced a remarkable picture of the medial side of the lower leg. In practice, the colorized 3D showed the complex latticework of large and small vessels inside the leg and the blood flow through it. In comparison to any other type of medical imaging, the detail is unmatched. Luxonus used its novel devices, a game-altering photoacoustic 3D scanner that employs the novel science of photoacoustic imaging.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key players in the photoacoustic tomography market are Advantest Corporation; Fujifilm VisualSonics Inc., Seno Medical, PreXion, iThera Medical GmbH, InnoLas Laser GmbH, OPOTEK LLC, CYBERDYNE INC., TomoWave Laboratories, Inc., Aspectus GmbH, Endra, Inc., and others.
Market players have adopted strategies such as product approvals, product launches, market initiatives, and mergers and acquisitions. For example, in June 2020, FUJIFILM VisualSonics Inc, a subsidiary of FUJIFILM SonoSite, Inc, launched Vevo F2, the world’s first ultra-high-to-low-frequency ultrasound imaging system with a frequency range of 71-1 MHz.
In February 2022, FUJIFILM VisualSonics Inc and PIUR IMAGING, the European giant in tomographic ultrasound imaging, partnered to introduce UHF, which is a three-dimensional (3D) ultrasound imaging technology to researchers and clinicians.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 13.60% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The growth outlook for the photoacoustic tomography market is predicted to advance at a CAGR of 13.60% from 2022 to 2032.
The North American region is anticipated to lead the photoacoustic tomography market during the forecast period.
The photoacoustic tomography market is likely to hold a valuation of US$ 320.9 million by 2032.
1. Executive Summary | Photoacoustic Tomography Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032 5.3.1. Diagnosis & Monitoring 5.3.2. Clinical Research 5.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals 6.3.2. Diagnostics Imaging Centers 6.3.3. Academic and Research Institutes 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. United States of America 8.2.1.2. Canada 8.2.2. By Application 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Application 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Application 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Application 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Application 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Application 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. India 11.2.1.5. Malaysia 11.2.1.6. Singapore 11.2.1.7. Australia 11.2.1.8. New Zealand 11.2.1.9. Rest of Asia-Pacific 11.2.2. By Application 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Application 11.3.3. By End User 11.4. Key Takeaways 12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of Middle East and Africa 12.2.2. By Application 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Application 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. United States of America 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Application 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Application 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Application 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Application 13.4.2.2. By End User 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Application 13.5.2.2. By End User 13.6. United Kingdom 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Application 13.6.2.2. By End User 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Application 13.7.2.2. By End User 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Application 13.8.2.2. By End User 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Application 13.9.2.2. By End User 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Application 13.10.2.2. By End User 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Application 13.11.2.2. By End User 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Application 13.12.2.2. By End User 13.13. Malaysia 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Application 13.13.2.2. By End User 13.14. Singapore 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Application 13.14.2.2. By End User 13.15. Australia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Application 13.15.2.2. By End User 13.16. New Zealand 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Application 13.16.2.2. By End User 13.17. GCC Countries 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Application 13.17.2.2. By End User 13.18. South Africa 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Application 13.18.2.2. By End User 13.19. Israel 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Application 13.19.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Application 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Fujifilm VisualSonics Inc. 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. PreXion 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. I Thera Medical GmbH 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Endra, Inc. 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. TomoWave Laboratories, Inc. 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. OPOTEK LLC. 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. Seno Medical Instruments 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. Advantest Corporation 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. Aspectus GmbH 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. kibero 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Healthcare
December 2017
REP-GB-5826
October 2022
217 pages
Explore Healthcare Insights
View Reports
Photoacoustic Tomography Market
